Geode Capital Management’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Geode Capital Management’s Portfolio SYRA Stock Details SYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-68,816	Closed	-$17.9K	–	4562
2025 Q1	$17.9K	Buy	68,816 +45,332	+193%	+$19K	﹤0.01%	4371
2024 Q4	$9.42K	Buy	23,484 +1,626	+7%	+$654	﹤0.01%	4445
2024 Q3	$9.27K	Buy	21,858 +8,875	+68%	+$9.41K	﹤0.01%	4481
2024 Q2	$17.8K	Sell	12,983 -12,590	-49%	-$17.2K	﹤0.01%	4471
2024 Q1	$35.3K	Buy	+25,573	New	+$41.3K	﹤0.01%	4388

Other funds holding SYRA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Geode Capital Management's SYRA Position: Q2 2025 in Review

Geode Capital Management sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q2 2025, closing a stake of 68,816 shares — an estimated $17.9K sold.

Geode Capital Management first reported a position in SYRA in Q1 2024 and held it in 5 quarters. The position peaked at $35.3K in Q1 2024. 2 funds tracked by Wall St. Rank hold SYRA as of Q2 2025.

Geode Capital Management reported no remaining Syra Health Corp. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
Geode Capital Management sold 68,816 Syra Health Corp. Class A Common Stock shares in Q2 2025, an estimated $17.9K.
Geode Capital Management first reported a position in Syra Health Corp. Class A Common Stock in Q1 2024 and held it in 5 quarters.
Geode Capital Management's Syra Health Corp. Class A Common Stock position peaked at $35.3K in Q1 2024.
2 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.